The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer.

Biochim Biophys Acta 2002 Jan;1586(1):11-22

Department of Oral and Maxillofacial Surgery, Graduate School of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan.

Matrix metalloproteinase-9 (MMP-9) produced by tumor cells is known to be implicated in the invasion of squamous cell carcinoma (SCC). In the process of searching for agents to inhibit MMP-9 in cancer, immunosuppressive factors, dexamethasone (DEX) and interleukin-4 (IL-4) were found to inhibit protein production as well as gene expression of MMP-9 in tumor necrosis factor alpha (TNFalpha)-stimulated SCC cells. DEX and IL-4 could also suppress the expression of urokinase type plasminogen activator (uPA) to prevent the conversion from the proenzyme form of MMP-9 to its active form. Regarding their mechanisms to inhibit the expression of MMP-9 and uPA, DEX and IL-4 had no effect on the cell surface levels of TNFalpha receptors, but inhibited the activation of NF-kappaB and NF-kappaB-dependent gene expression. DEX, but not IL-4, could strongly augment the TNFalpha-induced expression of IkappaBalpha in SCC cells. These results suggest that DEX and IL-4 suppress not only immunological reactions, but also tumor invasion by targeting NF-kappaB.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0925-4439(01)00080-1DOI Listing
January 2002
4 Reads

Publication Analysis

Top Keywords

dex il-4
16
gene expression
8
scc cells
8
cells dex
8
factors dexamethasone
8
il-4 suppress
8
expression mmp-9
8
immunosuppressive factors
8
il-4
5
mmp-9
5
expression
5
dex
5
form mmp-9
4
type plasminogen
4
conversion proenzyme
4
proenzyme form
4
activator upa
4
urokinase type
4
prevent conversion
4
upa prevent
4

Similar Publications